Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr 22;84(5):1255-1261.
doi: 10.1128/IAI.01544-15. Print 2016 May.

Experimental Models of Vaginal Candidiasis and Their Relevance to Human Candidiasis

Affiliations
Review

Experimental Models of Vaginal Candidiasis and Their Relevance to Human Candidiasis

Antonio Cassone et al. Infect Immun. .

Abstract

Vulvovaginal candidiasis (VVC) is a high-incidence disease seriously affecting the quality of life of women worldwide, particularly in its chronic, recurrent forms (RVVC), and with no definitive cure or preventive measure. Experimental studies in currently used rat and mouse models of vaginal candidiasis have generated a large mass of data on pathogenicity determinants and inflammation and immune responses of potential importance for the control of human pathology. However, reflection is necessary about the relevance of these rodent models to RVVC. Here we examine the chemical, biochemical, and biological factors that determine or contrast the forms of the disease in rodent models and in women and highlight the differences between them. We also appeal for approaches to improve or replace the current models in order to enhance their relevance to human infection.

PubMed Disclaimer

References

    1. Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner JJ. 2013. Prevalence recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis 17:340–345. doi: 10.1097/LGT.0b013e318273e8cf. - DOI - PubMed
    1. Ringdahl EN. 2006. Recurrent vulvovaginal candidiasis. Mo Med 103:165–168. - PubMed
    1. Sobel JD. 9 July 2015. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol doi: 10.1016/j.ajog.2015.06.067. - DOI - PubMed
    1. Cassone A. 2015. Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects. BJOG 122:785–794. doi: 10.1111/1471-0528.12994. - DOI - PubMed
    1. Cassone A, Boccanera M, Adriani D, Santoni G, De Bernardis F. 1995. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 63:2619–2624. - PMC - PubMed

LinkOut - more resources